SCHEMBL17895179

SCHEMBL17895179

NCCNc1nc2c(N)cccc2n2c(-c3ccc(O)c(O)c3)cnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 16/20 0.39
▸ CHUK O15111 15/20 0.39
▸ CDK11B P21127 2/20 0.39
▸ CDK7 P50613 2/20 0.39
▸ CDK13 Q14004 2/20 0.39
▸ MAP3K19 Q56UN5 2/20 0.39
▸ MYLK4 Q86YV6 2/20 0.39
▸ CDK11A Q9UQ88 2/20 0.39
▸ ERN1 O75460 1/20 0.39
▸ RPS6KA4 O75676 1/20 0.39
▸ PRKD3 O94806 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ CSNK1D P48730 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ LIMK1 P53667 1/20 0.39
▸ CDK16 Q00536 1/20 0.39
▸ MAPK7 Q13164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17895202 0.94 BRD4 (0.39) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895225 0.93 BRD4 (0.42) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895073 0.87 IKBKB (0.41) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895295 0.87 IKBKB (0.37) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL22099685 0.87 IKBKB (0.40) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895252 0.86 MIF (0.39) IKBKBCHUKMIFADORA3ADORA2A
SCHEMBL17895085 0.85 IKBKB (0.48) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895297 0.82 ADORA2A (0.43) IKBKBCHUKMIFADORA3ADORA2A
SCHEMBL17895187 0.82 BRD4 (0.37) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL17895194 0.82 BRD4 (0.39) IKBKBCHUKCDK11BCDK7CDK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3240789-B1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIV MONTPELLIER (FR) 2020-07-29 — — EP claimed
EP-3240789-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER Université de Montpellier (FR) 2017-11-08 — — EP claimed
WO-2016107895-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIVERSITE DE MONTPELLIER (FR) 2016-07-07 — — WO claimed
EP-3240789-B1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIV MONTPELLIER (FR) 2020-07-29 — — EP disclosed
EP-3240789-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER Université de Montpellier (FR) 2017-11-08 — — EP disclosed
WO-2016107895-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIVERSITE DE MONTPELLIER (FR) 2016-07-07 — — WO disclosed
Send feedback